title: [Update on the management of trigeminal neuralgia].
abstract: Trigeminal neuralgia is one of the most severe facial pain syndromes. The annual incidence varies between 4-13% and has a significant effect on patient quality of life. The initial treatment of trigeminal neuralgia is pharmacological, and although other drugs have demonstrated efficacy, albeit in more limited form, carbamazepine is the only drug with sufficient level of evidence. When medical treatment fails, surgery should be considered and can opt for open surgery or minimally invasive percutaneous techniques. This paper reviews the medical and surgical therapeutic options for the treatment of trigeminal neuralgia, based on current available evidence.
authors.affiliation: Centro de Salud José María Álvarez, Don Benito, Badajoz, España; Grupo de Trabajo de Dolor de SEMERGEN, España. Electronic address: a.alcantara.montero@hotmail.com.
authors.forename: A
authors.initials: A
authors.lastname: Alcántara Montero
authors.affiliation: Servicio de Urgencias, Hospital San Pedro de Alcántara, Cáceres, España.
authors.forename: C I
authors.initials: CI
authors.lastname: Sánchez Carnerero
mesh_terms: D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use*; D006801:Humans; D019060:Minimally Invasive Surgical Procedures / Q000379:methods; D011788:Quality of Life; D014277:Trigeminal Neuralgia / Q000503:physiopathology / Q000628:therapy*
chemical_list: D018712:Analgesics, Non-Narcotic; D002220:Carbamazepine
keywords: Actualización; Neuralgia del trigémino; Opciones de tratamiento; Treatment options; Trigeminal neuralgia; Update